Vyne Therapeutics
VYNE • NASDAQ
Vyne Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David T. Domzalski, with a market cap of $21.3M.
Market Cap$21.3M
Employees10.0
CEODavid T. Domzalski
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Vyne Therapeutics FAQ
Common questions about Vyne Therapeutics
Vyne Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026 before market open. Analysts estimate revenue of $200.0K.
Vyne Therapeutics has approximately 10 employees.